|
|
|
 |
|
|
 |
 |
Elan Corporation PLC
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Elan Corporation PLC. The Group's principal activity is discovering, developing, manufacturing and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. The Group's operations are carried out through two divisions. Elan Drug Technologies focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Biopharmaceuticals relates to the research, development and commercial activities in the areas of autoimmune diseases, neurodegenerative diseases and specialty business. The Group's product brands are Azactam, Maxipime, MXDAS, NanoCrystal, Naprelan, Prialt, SODAS, Tysabri and Verelan.
|
|
| |
Wright Quality Rating:
ALNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
5.22
(Figures in
Euro) |
|
1 Week |
-4.7% |
|
13 Weeks |
1.7% |
|
|
|
|
|
|
|
|
|
4 Weeks |
27.4% |
|
52 Weeks |
-15.0% |
|
|
|
| |
| |
Elan Corporation PLC
Key Data: |
|
|
|
| |
Ticker: |
DRX |
Country: |
IRELAND |
| |
|
| |
Exchanges: |
NYSE LON DUB |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Diversified Drugs, Cosmetics, & Health Care |
| |
|
| |
2008
Sales |
518,404,900
(Year Ending Jan 2009). |
Employees: |
1,687 |
| |
|
| |
Currency: |
Euro |
Market Cap: |
3,048,641,199 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
584,030,881 |
| |
|
| |
Share Type: |
Ordinary |
Closely Held Shares: |
72,105,479 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Elan Corporation PLC, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Elan Corporation PLC company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Elan Corporation PLC Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Elan Corporation PLC
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Elan Corporation PLC Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|